This FDA Drug Safety Communication was originally published on May 16, 2017, and is republished now as part of the FDA's effort to enhance drug safety communication.

The U.S. Food and Drug Administration (FDA) has asked the manufacturer of the leukemia chemotherapy drug Iclusig (ponatinib) to suspend marketing and sales of Iclusig because of the risk of life ...

Last week, the Food and Drug Administration (FDA) issued a safety communication warning the public about the potential risks of false results with genetic non-invasive prenatal screening tests ...

FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the ...

FDA Plans Reforms To Boost Drug Safety, Increase Communication. FDA on Tuesday announced several initiatives designed to improve prescription drug safety, including increased monitoring of adverse ...

FDA panel rejects drug that could combat rare terminal illness 02:40 "Some people might think it's alarming that one in three drugs are having a safety problem after approval.If you believe this ...

This guidance replaces an earlier version issued in May 2005, when FDA proposed a new communication channel -- the "Drug Watch" Web page -- to provide information on emerging drug safety issues.

At a town hall meeting in Atlanta today, FDA officials said they are taking several steps to address public perception that they are not tending well to drug safety. By building in moretime for ...

US Food and Drug Administration. Accolade pacemaker devices by Boston Scientific and potential need for early device replacement - FDA safety communication. Published and accessed on: December 16, ...

To address that question head on, the FDA held a November 7 hearing under the title, “Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs.” ...

To explore these questions, we selected new drug-safety communications related to prescription medicines that were issued by the U.S. Food and Drug Administration (FDA) over a 2-year period ...